No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome

39Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

One-third of first-degree relatives of patients with primary Sjögren's syndrome (pSS) suffer from other autoimmune diseases, including type I diabetes, systemic lupus erythematosus and autoimmune thyroiditis. Recently, 1858 C/T polymorphism of PTPN22 gene was reported to predispose to these autoimmune diseases. We decided to investigate whether PTPN22 gene polymorphism was also involved in the genetic predisposition to pSS in a case -control study, including 183 patients with pSS and 172 healthy controls. No significant differences in allele (T allele frequency: 7.7% in patients with pSS vs 7.8% in controls, P = 0.9) and genotype frequencies of PTPN22 polymorphism were detected between patients with pSS and controls. PTPN 22 gene polymorphism was not associated with a specific pattern of autoantibody secretion either. Thus, 1858 C/T polymorphism of PTPN22 gene is not involved in genetic predisposition to pSS. © 2005 Natures Publishing Group All rights reserved.

Cite

CITATION STYLE

APA

Ittah, M., Gottenberg, J. E., Proust, A., Hachulla, E., Puechal, X., Loiseau, P., … Miceli-Richard, C. (2005). No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren’s syndrome. Genes and Immunity, 6(5), 457–458. https://doi.org/10.1038/sj.gene.6364229

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free